ATP Fund

$Million of Cumulative Funding (All-in)

Years of Venture Experience

$Million of Cumulative Funding

Software may be “eating the world”, but it is engineering and science that is going to save it

The ATP team brings together the critical components of the Research-to-Development (R-to-D) ecosystem, specifically:

• INNOVATORS with national lab, university, and corporate R&D groups;
• ENTREPRENEURS: both first-time and seasoned executives;
• INVESTMENT PARTNERS: top-tier VC firms and our own syndication networks;
• CORPORATIONS: the key stakeholder to ensure Demand meets Supply
• This diversity brings value-add from zero to one and beyond

Impact Themes – Powering the Future of…

Emerging Research (Deep Tech)

From behavioral research (the mind) and innovations in therapeutics & diagnostics (the body) to the practice and delivery of medical treatments (the world), improving health outcomes is paramount Addressing emerging systems approaches of an interconnected world, focusing on resiliency and sustainability Stakeholder management; Workforce shifts due to machine learning and AI; Impact of quantum and distributed ledger tech on information security Example area of focus: US “Freshwater” & Canadian universities receive over $58B of research funding annually yet are severely under utilized by the traditional venture capital industry ATP works directly with innovators from the early research-translation to later phases, with particular emphasis on Pre-seed (Launch), Seed (Nurture) and Series A (Scale) funding stages ATP powers the earliest stages of firm development, creating returns for our investors and sustainable impact in target categories such as: economic development in underserved regions and gender-disparity access

Early-stage VC continues to outperform, Global cash is still seeking yields, Formation & early-stage is where wealth is created Overlooked, underserved, and complex markets are ripe for more early-stage venture funding

#3 Privileged deal flow

Result of team’s long-standing relationships across university-anchored markets, national research labs, and strategic corporate partners

#4 The old normal

Expanded service offering: Following existing best-in-class incubation organizations with our own proven “ATP-Proto n” acceleration process enhances the resources available to portfolio investments